Health
CureVac’s COVID vaccine enters EMA’s rolling review – Regulatory Focus
EMA’s human medicines committee (CHMP) will review available data on CureVac’s messenger RNA (mRNA) vaccine CVnCoV. The vaccine is currently being tested in a Phase…
Just Released: Regulatory Writing: An Overview
An invaluable resource for any professional engaged in designing, composing, compiling, or commenting on regulatory documentation
BUY NOW
Continue Reading